BUUU Group Limited (BUUU) priced its initial public offering of 1.5 million Class A ordinary shares at $4.00 per share, according to a company statement. The Hong Kong-based meetings, incentives, ...

TScan Therapeutics operates in the U.S. Small & Mid Cap Biotechnology sector, concentrating on innovative therapies for both hematological malignancies and solid tumors. The company’s primary focus ...

SEOUL (Reuters) -The North Korean leader’s powerful sister said on Thursday that the country has never taken down propaganda ...